Gut Transit in Celiac Disease: Delay of Small Bowel Transit and Acceleration after Dietary Treatment

2004 ◽  
Vol 99 (12) ◽  
pp. 2429-2436 ◽  
Author(s):  
Riadh Sadik ◽  
Hasse Abrahamsson ◽  
Anders Kilander ◽  
Per-Ove Stotzer
2021 ◽  
Author(s):  
Khalid Elias ◽  
Per M. Hellström ◽  
Dominic-Luc Webb ◽  
Magnus Sundbom

Abstract Purpose Bariatric surgery alters gastrointestinal anatomy. In this exploratory study, the SmartPill® wireless motility capsule (WMC) was used to study changes in gastrointestinal physiology following biliopancreatic diversion with duodenal switch (BPD/DS). Material and Methods Twenty-eight BPD/DS patients (35 ± 11 years, 50% females, body mass index [BMI] 56 ± 5) were to be examined preoperatively and postoperatively. In addition to transit time, appetite control and gastrointestinal symptoms were studied by patient-scored questionnaires (visual analogue scale and Gastrointestinal Symptom Rating Scale (GSRS)). Data was compared to 41 lean unoperated controls. Results About 1.8 years postoperatively, 18 patients (BMI 35.8 ± 8.3) returned for a second WMC test. As expected, small bowel transit time was reduced, from 3.9 ± 1.6 h to 2.8 ± 2.0, p = 0.02, and at both these time points, it was shorter than in lean controls (5.4 ± 1.9 h, p = 0.001). Postoperatively, a trend towards reduced colon and whole gut transit times was seen in BPD/DS-patients, thus approaching those of lean controls. Surprisingly, BPD/DS patients scored higher satiety than controls preoperatively as well as increased hunger and desire to eat postoperatively. Compared to lean, BPD/DS patients reported a higher total GSRS score at both time points (1.2 ± 0.2 vs 1.7 ± 0.6 and 2.3 ± 0.5, p < 0.001). Postoperatively, the scores for diarrhea and indigestion increased. Conclusions The novel use of the SmartPill system in BPD/DS patients gave the expected readouts. Although small bowel transit time was further shortened after BPD/DS, whole gut transit time did not differ from controls. Typical gastrointestinal symptoms were reported postoperatively. Graphical abstract


2000 ◽  
Vol 14 (11) ◽  
pp. 919-921 ◽  
Author(s):  
Helen Rachel Gillett ◽  
Hugh James Freeman

Both collagenous and lymphocytic colitis have been described in patients with celiac disease, suggesting an association between the conditions. Over the past few years, the availability, sensitivity and specificity of serological markers for celiac disease have improved - the most recent advancement being the description of tissue transglutaminase as the major antigen for endomysium antibody. A quantitative ELISA was used to measure titres of immunoglobulin A (IgA) antibody to tissue transglutaminase (tTG) along with an immunofluorescent technique for IgA endomysium antibody (EmA) in 15 patients with lymphocytic colitis and eight with collagenous colitis to determine whether celiac disease latency could be detected. One patient with lymphocytic colitis demonstrated both elevated titres of tTG antibody and positive EmA, and small bowel biopsy confirmed celiac disease. One patient with collagenous colitis had a slightly elevated titre of tTG antibody with a negative EmA, and results of a small bowel biopsy were normal. Three other patients with lymphocytic colitis were already treated for previously diagnosed celiac disease. The prevalence of celiac disease occurring in lymphocytic colitis was found to be 27%, but no cases of celiac disease in association with collagenous colitis were found.


1992 ◽  
Vol 79 (7) ◽  
pp. 697-700 ◽  
Author(s):  
W. A. Kmiot ◽  
J. D. O'Brien ◽  
R. Awad ◽  
M. R. B. Keighley

2017 ◽  
Vol 86 (2) ◽  
pp. 264-273.e1 ◽  
Author(s):  
Luca Elli ◽  
Giovanni Casazza ◽  
Martina Locatelli ◽  
Federica Branchi ◽  
Francesca Ferretti ◽  
...  

2004 ◽  
Vol 199 (3) ◽  
pp. 86
Author(s):  
D.Dean Potter ◽  
Joseph Murray ◽  
John Donohue ◽  
Lawrence Burgart ◽  
David Nagorney ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document